|
Nature of Operations and Basis of Presentation (Details) (USD $)
|
0 Months Ended | ||
|---|---|---|---|
|
May 18, 2015
|
Jun. 03, 2011
|
Apr. 30, 2015
subsidiary
|
|
| Nature of operations and basis of presentation | |||
| Number of subsidiaries | 0oncs_NumberOfSubsidiaries | ||
| Reverse stock split ratio | 0.05us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 | ||
| Number of fractional shares issued related to reverse stock split | 0oncs_NumberOfFractionalSharesIssuedRelatedToStockSplit | ||
| OncoSec Medical Therapeutics | |||
| Nature of operations and basis of presentation | |||
| Total purchase price |
$ 1,000us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = oncs_OncoSecMedicalTherapeuticsIncorporatedMember |
||
| X | ||||||||||
|
- Definition
Represents the number of fractional shares issued due to a stock split. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the number of subsidiaries of the Company. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|